Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease
Facundo Maiorana; Magali Neschuk; María Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro;
10.1016/j.aohep.2024.101541
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018
Tongtong Wang; Yuzhi Xi; Annaswamy Raji; Michael Crutchlow; Gail Fernandes; Samuel S Engel; Xiao Zhang;
Ann Hepatol. 2024;29: